V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004563 | 220015826 | 1.53 | null | Palliative (P) | 2013-12-23 | 2013-12-23 | Cytarabine Low Dose | 99 | N | 220026310 | CYTARABINE |
| 220004564 | 220001815 | null | 97.8 | Curative (C) | 2013-02-14 | 2013-02-14 | LI-1 TRIAL | null | null | 220026312 | TRIAL |
| 220004565 | 220001815 | 1.69 | null | Curative (C) | 2017-10-02 | 2017-10-04 | AML17 TRIAL | N | N | 220026312 | AML17 TRIAL |
| 220004566 | 220001816 | null | null | Disease modification (D) | 2014-10-30 | 2014-11-09 | Cytarabine Low Dose | null | null | 220026318 | CYTARABINE |
| 220004567 | 220001816 | null | 92.2 | Curative (C) | null | 2013-07-24 | AML17 TRIAL | N | N | 220026318 | AML17 TRIAL |
| 220004568 | 220001817 | 1.67 | null | null | 2017-09-23 | 2017-09-24 | Cytarabine Low Dose | 02 | N | 220026323 | CYTARABINE |
| 220004569 | 220001818 | 1.57 | 80 | Curative (C) | null | 2013-07-12 | AML17 TRIAL | N | N | 220026325 | AML17 TRIAL |
| 220004570 | 220001819 | 1.7 | 88.3 | null | 2015-01-30 | 2015-01-31 | Cytarabine Low Dose | Y | null | 220026326 | CYTARABINE |
| 220004571 | 220010920 | 1.67 | 190.1 | Curative (C) | 2014-08-04 | 2014-08-18 | AML17 TRIAL | null | N | 220026329 | AML17 TRIAL |
| 220004572 | 220010920 | 1.64 | 72 | Not known (9) | 2013-02-24 | 2013-03-03 | AML17 TRIAL | 02 | N | 220026329 | AML17 TRIAL |
| 220004573 | 220001820 | 1.8 | 62.2 | Adjuvant (A) | 2017-09-06 | 2017-09-06 | AML17 TRIAL | Y | N | 220026332 | AML17 TRIAL |
| 220004574 | 220001821 | 1.67 | 52 | Curative (C) | null | 2014-05-11 | Trial Unspecified | null | null | 220026333 | TRIAL |
| 220004575 | 220001822 | 1.77 | 69.5 | null | 2013-01-15 | 2013-01-23 | AML17 TRIAL | null | null | 220026335 | AML17 TRIAL |
| 220004576 | 220010921 | 1.31 | 77.4 | Disease modification (D) | 2015-07-16 | 2015-07-18 | Trial Unspecified | 01 | N | 220026338 | TRIAL |
| 220004577 | 220010921 | 1.85 | null | Palliative (P) | 2016-07-03 | 2016-07-04 | CYTARABINE | N | N | 220026338 | CYTARABINE |
| 220004578 | 220018674 | 1.85 | 70 | Curative (C) | 2015-06-03 | 2015-06-03 | Trial Unspecified | Y | N | 220026352 | TRIAL |
| 220004579 | 220018674 | 1.84 | 80 | null | 2016-07-15 | 2016-07-20 | Cytarabine Low Dose | N | N | 220026352 | CYTARABINE |
| 220004580 | 220001823 | 1.78 | 92 | Not known (9) | 2017-09-19 | 2017-09-20 | AML17 TRIAL | 1 | N | 220026354 | AML17 TRIAL |
| 220004581 | 220001823 | 1.45 | 76.3 | Not known (9) | 2016-07-26 | 2016-07-26 | AML17 TRIAL | 1 | N | 220026354 | AML17 TRIAL |
| 220004582 | 220001823 | 1.83 | 83.5 | null | 2017-03-13 | 2017-03-13 | Cytarabine Low Dose | null | N | 220026354 | CYTARABINE |
| 220004583 | 220001823 | 1.66 | 84.6 | Curative (C) | 2013-03-11 | 2013-03-14 | AML17 TRIAL | 01 | N | 220026354 | AML17 TRIAL |
| 220004585 | 220001824 | 1.65 | 86.1 | null | 2017-10-31 | 2017-10-31 | Cytarabine Low Dose | N | N | 220026364 | CYTARABINE |
| 220004586 | 220001824 | 1.65 | 42.9 | Palliative (P) | null | 2014-08-22 | CYTARABINE | N | N | 220026364 | CYTARABINE |
| 220004587 | 220001824 | 1.6 | null | Disease modification (D) | 2016-12-14 | 2016-12-21 | Cytarabine Low Dose | N | N | 220026364 | CYTARABINE |
| 220004588 | 220001824 | null | null | Curative (C) | 2017-03-15 | 2017-03-15 | AML17 TRIAL | 1 | null | 220026364 | AML17 TRIAL |
| 220004589 | 220001824 | null | 74.5 | Palliative (P) | 2014-12-15 | 2014-12-15 | Cytarabine Low Dose | Y | null | 220026364 | CYTARABINE |
| 220004590 | 220001824 | null | 85 | Palliative (P) | 2017-01-29 | 2017-02-09 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026364 | CYTARABINE |
| 220004591 | 220021697 | 1.63 | null | Curative (C) | null | 2014-09-16 | Cytarabine Low Dose | 02 | null | 220026379 | CYTARABINE |
| 220004592 | 220021982 | null | 73 | Not known (9) | 2014-02-17 | 2014-02-17 | Trial Unspecified | N | N | 220026380 | TRIAL |
| 220004593 | 220021982 | 1.62 | 69.4 | Palliative (P) | 2013-08-26 | 2013-08-26 | Trial Unspecified | null | N | 220026380 | TRIAL |
| 220004594 | 220001825 | 1.64 | null | Palliative (P) | 2015-11-09 | 2015-11-09 | Cytarabine Low Dose | 99 | N | 220026384 | CYTARABINE |
| 220004595 | 220001825 | 1.59 | 75 | Not known (9) | 2017-02-14 | 2017-02-14 | AML17 TRIAL | null | null | 220026384 | AML17 TRIAL |
| 220004596 | 220001826 | 0 | 88.95 | Curative (C) | 2013-01-22 | 2013-01-26 | Trial Unspecified | Y | null | 220026390 | TRIAL |
| 220004597 | 220001826 | null | 98 | Curative (C) | 2017-06-18 | 2017-06-18 | AML17 TRIAL | 1 | null | 220026390 | AML17 TRIAL |
| 220004599 | 220010926 | 1.77 | 66 | Palliative (P) | 2014-05-27 | 2014-05-27 | AML17 TRIAL | 01 | N | 220026393 | AML17 TRIAL |
| 220004600 | 220010926 | 1.62 | null | Palliative (P) | 2017-03-22 | 2017-03-22 | Cytarabine Low Dose | 2 | N | 220026393 | CYTARABINE |
| 220004601 | 220010926 | 1.67 | 78 | null | 2014-05-23 | 2014-05-23 | AML17 TRIAL | 01 | N | 220026393 | AML17 TRIAL |
| 220004602 | 220001828 | 1.84 | 104 | Palliative (P) | 2013-03-30 | 2013-03-30 | CYTARABINE | N | N | 220026400 | CYTARABINE |
| 220004603 | 220001828 | 1.59 | 80.8 | Curative (C) | 2013-04-18 | 2013-04-19 | AML17 TRIAL | N | N | 220026400 | AML17 TRIAL |
| 220004604 | 220001829 | null | 77 | Not known (9) | 2017-05-07 | 2017-05-23 | CYTARABINE | N | N | 220026408 | CYTARABINE |
| 220004607 | 220001831 | 1.59 | 78 | Curative (C) | 2014-11-21 | 2014-11-21 | Trial Unspecified | Y | null | 220026416 | TRIAL |
| 220004608 | 220001832 | null | 114.1 | Curative (C) | 2015-05-05 | 2015-05-05 | Trial Unspecified | Y | N | 220026418 | TRIAL |
| 220004609 | 220001832 | 1.71 | null | Curative (C) | 2014-02-02 | 2014-02-06 | AML17 TRIAL | 01 | N | 220026418 | AML17 TRIAL |
| 220004610 | 220001832 | null | 104.2 | Curative (C) | 2017-10-26 | 2017-11-02 | AML17 TRIAL | Y | N | 220026418 | AML17 TRIAL |
| 220004611 | 220001832 | 1.67 | 58 | Curative (C) | 2015-01-09 | 2015-01-13 | AML17 TRIAL | 02 | N | 220026418 | AML17 TRIAL |
| 220004612 | 220001833 | 1.62 | 63.3 | Curative (C) | 2014-02-14 | 2014-02-14 | AML17 TRIAL | 01 | N | 220026427 | AML17 TRIAL |
| 220004613 | 220001833 | 1.9 | 93.6 | Curative (C) | 2017-10-06 | 2017-10-06 | Trial Unspecified | 1 | null | 220026427 | TRIAL |
| 220004614 | 220001833 | 1.64 | null | Curative (C) | 2014-01-19 | 2014-01-21 | Trial Unspecified | Y | N | 220026427 | TRIAL |
| 220004615 | 220001833 | 1.63 | 73.4 | Palliative (P) | 2015-01-08 | 2015-01-14 | Trial Unspecified | N | N | 220026427 | TRIAL |
| 220004616 | 220001833 | 1.56 | null | Palliative (P) | 2015-10-08 | 2015-10-08 | Cytarabine Low Dose | null | N | 220026427 | CYTARABINE |